首页> 美国卫生研究院文献>Springer Open Choice >Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995–2004)

【2h】

Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995–2004)

机译：在亚伯达省接受化疗的转移性结直肠癌患者的生存率（1995年至2004年）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Goals of workClinical trials have suggested that advances in chemotherapy significantly improve the survival of patients with metastatic colorectal cancer. Comparable evidence from clinical practice is scarce. This study aims to investigate the survival of patients with metastatic colorectal cancer treated with chemotherapy in Alberta, Canada.

机译：工作目标临床试验表明，化学疗法的进步显着提高了转移性结直肠癌患者的生存率。临床实践中缺乏可比的证据。这项研究旨在调查在加拿大艾伯塔省接受化疗的转移性结直肠癌患者的生存情况。

著录项

期刊名称 Springer Open Choice
作者
Yiqun Chen; Zhenguo Qiu; Anmmd Kamruzzaman; Tom Snodgrass; Andrew Scarfe; Heather E. Bryant;
展开▼
作者单位

展开▼
年(卷),期 -1(18),2
年度 -1
页码 217–224
总页数 8
原文格式 PDF
正文语种
中图分类外科学;
关键词
Metastatic colorectal cancer Chemotherapy Overall survival;

机译：转移性结直肠癌;化疗;总生存;

相似文献

外文文献
中文文献
专利

1. Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995–2004) [J] . Yiqun Chen, Zhenguo Qiu, Anmmd Kamruzzaman, Supportive Care in Cancer . 2010,第2期

机译：在亚伯达省接受化疗的转移性结直肠癌患者的生存率（1995年至2004年）
2. Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995-2004). [J] . Chen Y, Qiu Z, Kamruzzaman A, Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2010,第2期

机译：阿尔伯塔省接受过化疗的转移性结直肠癌患者的生存率（1995-2004年）。
3. CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy [J] . Matsusaka S., Cao S., Hanna D. L., The pharmacogenomics journal . 2017,第6期

机译：CXCR4多态性预测，通过一线贝伐单抗化疗治疗的转移性结直肠癌患者的无进展生存
4. Correlation between development of hypertension and efficacy in metastatic colorectal cancer patients treated with bevacizumab [C] . Horinouchi Y., Sakurada T., Nakamura T., European Association for Clinical Pharmacology and Therapeutics . 2011

机译：北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
5. Impact of Erythropoiesis Stimulating Agents on Survival and Risk of Venous Thromboembolism Among Patients with Colorectal Cancer Receiving Chemotherapy. [D] . Sato, Masayo. 2012

机译：红细胞生成刺激剂对接受化疗的结直肠癌患者生存率和静脉血栓栓塞风险的影响。
6. Exploration of time points and cut-off values for early tumour shrinkage to predict survival outcomes of patients with metastatic colorectal cancer treated with first-line chemotherapy using a biexponential model for change in tumour size [O] . Kentaro Sakamaki, Yosuke Kito, Kentaro Yamazaki, 2017

机译：探索使用双指数模型改变肿瘤大小的一线化疗治疗的转移性结直肠癌患者早期肿瘤缩小的时间点和临界值以预测其生存结果
7. Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995–2004) [O] . Yiqun Chen, Zhenguo Qiu, Anmmd Kamruzzaman, 2009

机译：在亚伯达省接受化疗的转移性结直肠癌患者的生存率（1995年至2004年）

Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995–2004)

摘要

著录项

相似文献

相关主题

期刊订阅